- Home
- REYN vs DNTH Comparison
REYN vs DNTH Comparison
Compare REYN & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REYN | DNTH |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.9B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | REYN | DNTH |
|---|---|---|
| Price | $21.70 | $106.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | $24.83 | ★ $121.00 |
| AVG Volume (30 Days) | ★ 1.4M | 544.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $3,756,000,000.00 | $2,036,000.00 |
| Revenue This Year | $1.91 | N/A |
| Revenue Next Year | $1.82 | $29.48 |
| P/E Ratio | $76.96 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.44 | $32.28 |
| 52 Week High | $27.32 | $117.88 |
Technical Indicators
Market Signals| Indicator | REYN | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 44.50 |
| Support Level | $20.80 | $101.19 |
| Resistance Level | $22.46 | $107.99 |
| Average True Range (ATR) | 0.57 | 4.59 |
| MACD | -0.30 | -0.85 |
| Stochastic Oscillator | 1.50 | 26.26 |
Price Performance
Historical ComparisonAbout REYN Reynolds Consumer Products Inc.
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.